
Loading, please wait...

Loading, please wait...

Acute pediatric infections often drive families to emergency departments, yet many cases are manageable at home. To address this, researchers are developing a pediatric AI chatbot named CHAMP (CHatbot to Assist the Management of Pediatric patients). This innovative tool provides timely, tailored, and validated health information to help parents make informed care-seeking decisions. By bridging the gap between clinical expertise and at-home care, CHAMP aims to optimize healthcare resource utilization.
The CHAMP project employs a multiphase, mixed-methods participatory study design at the Montreal Children's Hospital. Initially, the team conducts a qualitative needs assessment to understand family preferences regarding pediatric infections. Subsequently, a coconstruction committee of parents and youth reviews clinical guidelines to map essential care questions. Furthermore, the study includes iterative prototyping and scenario testing to ensure high usability and acceptability among diverse users. Additionally, researchers evaluate an automated large language model-based translation layer to enhance multilingual accessibility.
Consequently, the study ensures that the final prototype is grounded in equitable and responsible AI development. Because the tool focuses on acute infectious symptoms, it addresses a major pain point in pediatric primary care. Moreover, the participatory approach empowers families as coresearchers, ensuring the technology aligns with their real-world needs. Therefore, CHAMP represents a significant step toward patient-centered digital health solutions.
Successful implementation of this pediatric AI chatbot could significantly reduce preventable emergency department visits. Furthermore, it ensures that high-risk children receive timely direction to appropriate clinical care. In the future, findings from this study will inform broader best practices for pediatric-centered AI health tools. Ultimately, such innovations improve the overall healthcare experience for both patients and their families.
CHAMP delivers evidence-based guidance tailored to a child's symptoms, helping parents determine if they can safely manage the illness at home or if they need to seek medical attention.
The chatbot is being coconstructed by a committee of youth, parents, caregivers, and partners to ensure the tool meets the actual needs and concerns of its end-users.
Yes, the study specifically includes a phase to evaluate a multilingual translation layer, aiming to bridge language barriers and promote digital equity for all families.
Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Lin J et al. Coconstructing CHAMP, an Artificial Intelligence Chatbot for Pediatric Infectious Symptoms Management: Protocol for a Multiphase Participatory Study. JMIR Res Protoc. 2026 May 26. doi: 10.2196/89852. PMID: 42189574.
Varghese C et al. Artificial intelligence: Revolutionizing pediatric emergency care - A narrative review. PMC. 2025 Sep 11.
UNICEF. Policy guidance on AI for children. 2.0. 2021.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers are protocolizing CHAMP, an AI chatbot designed to provide tailored health guidance for pediatric infectious symptoms and reduce ED crowding....
4 months ago

A recent study demonstrates that spinal oxygen sensors do not require mitochondrial electron transport to trigger sympathetic excitation during acute hypoxia, revealing new insights into how mitochondrial oxidative stress modulates autonomic tone in cardiovascular and neurological diseases.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today